NATIONALReuters US·5h ago
RNA drug developer ADARx seeks $1.74 billion valuation in US IPO - Reuters
AI TLDR · GEMINI
AI TLDR is temporarily unavailable (daily budget reached). Read the publisher summary below or try again later.
RNA drug developer ADARx seeks $1.74 billion valuation in US IPO Reuters
READ NEXT
More on the wire
national2m ago
FROM THE PUBLISHER
Flights have been paused at Newark Liberty International Airport in New Jersey and Philadelphia International Airport in Pennsylvania due to equipment outages.
events10m ago
FROM THE PUBLISHER
President Trump unveiled his new granite helipad on Monday, but none of the major TV networks carried the event as tensions between the media and the White House escalated.
politics12m ago
FROM THE PUBLISHER
Democrats are hopeful that Trump's low approval ratings and rising gas prices will make it impossible for Fitzpatrick to win reelection this year.